Acousia Therapeutics
Acousia Therapeutics is a biotech company in Tübingen, Germany, founded in 2012. It has raised $14.6M across 2 rounds, most recently an $11.7M Series B in May 2018.
Enhance & Preserve Natural Hearing
- Headquarters
- Tübingen
- Employees
- 1–10
- Founded
- 2012
- Business Model
- B2B
- Website
- acousia.com
- Total Funding
- $14.6M
- Last Round
- $11.7M Series BMay 2018
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
Acousia Therapeutics GmbH is a clinical-stage biotech company based in Tübingen, Germany, focused on developing novel small molecule drugs to treat sensorineural hearing loss (SNHL). Founded in 2012 by Hubert Löwenheim, the company operates under an exclusive collaboration with the Translational Hearing Research Group of Tübingen University Clinic. Acousia's lead drug candidates—ACOU085 (INN: Bimokalner) and ACOU082—are Kv7.4 activators with a dual mode of action suitable for both acute and chronic hearing loss. ACOU085 completed a Phase 2 PROHEAR study evaluating otoprotection against cisplatin-induced hearing loss in testicular cancer patients, with positive topline results reported in 2026. ACOU082 is in development for chronic hearing loss, hearing aid synergistic enhancement, and CNS indications. Sensorineural hearing loss affects more than 90% of the 1.5 billion people worldwide with hearing impairment, with no approved pharmacological treatments currently available.
Summary
It lists 1–10 employees. It has raised $14.6M in total across 2 rounds, most recently a $11.7M Series B round in May 2018. Investors include Boehringer Ingelheim Venture Fund, LBBW Venture Capital and KfW.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2018
Sign up to see all 2 events
Funding: Venture Round through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/acousia-therapeutics"><img src="https://indexed.vc/api/badge/company/acousia-therapeutics" alt="Acousia Therapeutics on Indexed.vc" width="260" height="76" /></a>